Alliance Boots Doubles Down In China With 12% Stake Of Nanjing Pharma
This article was originally published in PharmAsia News
Executive Summary
As MNCs increase stakes in China’s pharmaceutical distribution market, the highly segmented nature of the industry will remain a challenge for market penetration, analysts say.